Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CTXR holding history

Citius Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTXR overviewAll 13F holders of CTXRFull Q2 2026 holdings

Shares (Q2 2026)
44
Value
$27
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CTXR by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202644$27<0.1%−1,320−96.8%ReducedHolders
Q1 20261,364$1.23K<0.1%−668−32.9%ReducedHolders
Q4 20252,032$1.58K<0.1%+1,625+399.3%AddedHolders
Q3 2025407$504<0.1%+347+578.3%AddedHolders
Q2 202560$95<0.1%00.0%UnchangedHolders
Q1 202560$89<0.1%−258−81.1%ReducedHolders
Q4 2024318$1.27K<0.1%+258+430.0%AddedConverted for a 1-for-25 splitHolders
Q3 20241,500$751<0.1%−8,240−84.6%ReducedHolders
Q2 20249,740$5.69K<0.1%−181,927−94.9%ReducedHolders
Q1 2024191,667$172.0K<0.1%−52,292−21.4%ReducedHolders
Q4 2023243,959$184.6K<0.1%+167,943+220.9%AddedHolders
Q3 202376,016$52.0K<0.1%−28,005−26.9%ReducedHolders
Q2 2023104,021$124.8K<0.1%−32,468−23.8%ReducedHolders
Q1 2023136,489$159.7K<0.1%+25,115+22.6%AddedHolders
Q4 2022111,374$88.0K<0.1%−37,136−25.0%ReducedHolders
Q3 2022148,510$179.0K<0.1%−59,241−28.5%ReducedHolders
Q2 2022207,751$191.0K<0.1%+161,539+349.6%AddedHolders
Q1 202246,212$83.0K<0.1%+5,738+14.2%AddedHolders
Q4 202140,474$61.0K<0.1%+28,076+226.5%AddedHolders
Q3 202112,398$25.0K<0.1%+3,653+41.8%AddedHolders
Q2 20218,745$30.0K<0.1%−31,255−78.1%ReducedHolders
Q1 202140,000$71.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.